BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 22742967)

  • 1. Deciphering hERG channels: molecular basis of the rapid component of the delayed rectifier potassium current.
    Jonsson MK; van der Heyden MA; van Veen TA
    J Mol Cell Cardiol; 2012 Sep; 53(3):369-74. PubMed ID: 22742967
    [TBL] [Abstract][Full Text] [Related]  

  • 2. HERG mutation predicts short QT based on channel kinetics but causes long QT by heterotetrameric trafficking deficiency.
    Paulussen AD; Raes A; Jongbloed RJ; Gilissen RA; Wilde AA; Snyders DJ; Smeets HJ; Aerssens J
    Cardiovasc Res; 2005 Aug; 67(3):467-75. PubMed ID: 15958262
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characterization of hERG1a and hERG1b potassium channels-a possible role for hERG1b in the I (Kr) current.
    Larsen AP; Olesen SP; Grunnet M; Jespersen T
    Pflugers Arch; 2008 Sep; 456(6):1137-48. PubMed ID: 18504605
    [TBL] [Abstract][Full Text] [Related]  

  • 4. hERG1a and hERG1b potassium channel subunits directly interact and preferentially form heteromeric channels.
    McNally BA; Pendon ZD; Trudeau MC
    J Biol Chem; 2017 Dec; 292(52):21548-21557. PubMed ID: 29089383
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [HERG K+ channel, the target of anti-arrhythmias drugs].
    Guan FY; Yang SJ
    Yao Xue Xue Bao; 2007 Jul; 42(7):687-91. PubMed ID: 17882949
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Enhanced inhibitory effect of acidosis on hERG potassium channels that incorporate the hERG1b isoform.
    Du CY; El Harchi A; McPate MJ; Orchard CH; Hancox JC
    Biochem Biophys Res Commun; 2011 Feb; 405(2):222-7. PubMed ID: 21219869
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The cardiac hERG/IKr potassium channel as pharmacological target: structure, function, regulation, and clinical applications.
    Thomas D; Karle CA; Kiehn J
    Curr Pharm Des; 2006; 12(18):2271-83. PubMed ID: 16787254
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cardiac glycosides as novel inhibitors of human ether-a-go-go-related gene channel trafficking.
    Wang L; Wible BA; Wan X; Ficker E
    J Pharmacol Exp Ther; 2007 Feb; 320(2):525-34. PubMed ID: 17095614
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Determinants of Isoform-Specific Gating Kinetics of hERG1 Channel: Combined Experimental and Simulation Study.
    Perissinotti LL; De Biase PM; Guo J; Yang PC; Lee MC; Clancy CE; Duff HJ; Noskov SY
    Front Physiol; 2018; 9():207. PubMed ID: 29706893
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Molecular basis and drug sensitivity of the delayed rectifier (IKr) in the fish heart.
    Hassinen M; Haverinen J; Vornanen M
    Comp Biochem Physiol C Toxicol Pharmacol; 2015; 176-177():44-51. PubMed ID: 26215639
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Isoform-specific dominant-negative effects associated with hERG1 G628S mutation in long QT syndrome.
    Stump MR; Gong Q; Zhou Z
    PLoS One; 2012; 7(8):e42552. PubMed ID: 22876326
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 2-[2-(3,4-dichloro-phenyl)-2,3-dihydro-1H-isoindol-5-ylamino]-nicotinic acid (PD-307243) causes instantaneous current through human ether-a-go-go-related gene potassium channels.
    Gordon E; Lozinskaya IM; Lin Z; Semus SF; Blaney FE; Willette RN; Xu X
    Mol Pharmacol; 2008 Mar; 73(3):639-51. PubMed ID: 18042732
    [TBL] [Abstract][Full Text] [Related]  

  • 13. hERG1a/1b heteromeric currents exhibit amplified attenuation of inactivation in variant 1 short QT syndrome.
    McPate MJ; Zhang H; Cordeiro JM; Dempsey CE; Witchel HJ; Hancox JC
    Biochem Biophys Res Commun; 2009 Aug; 386(1):111-7. PubMed ID: 19501051
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Zebrafish cardiac repolarization does not functionally depend on the expression of the hERG1b-like transcript.
    Genge CE; Muralidharan P; Kemp J; Hull CM; Yip M; Simpson K; Hunter DV; Claydon TW
    Pflugers Arch; 2024 Jan; 476(1):87-99. PubMed ID: 37934265
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fentanyl-Induced Block of hERG Channels Is Exacerbated by Hypoxia, Hypokalemia, Alkalosis, and the Presence of hERG1b.
    Tschirhart JN; Zhang S
    Mol Pharmacol; 2020 Oct; 98(4):508-517. PubMed ID: 32321735
    [TBL] [Abstract][Full Text] [Related]  

  • 16. hERG1a N-terminal eag domain-containing polypeptides regulate homomeric hERG1b and heteromeric hERG1a/hERG1b channels: a possible mechanism for long QT syndrome.
    Trudeau MC; Leung LM; Roti ER; Robertson GA
    J Gen Physiol; 2011 Dec; 138(6):581-92. PubMed ID: 22124116
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The influence of hERG1a and hERG1b isoforms on drug safety screening in iPSC-CMs.
    Goversen B; Jonsson MK; van den Heuvel NH; Rijken R; Vos MA; van Veen TA; de Boer TP
    Prog Biophys Mol Biol; 2019 Dec; 149():86-98. PubMed ID: 30826123
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression of distinct ERG proteins in rat, mouse, and human heart. Relation to functional I(Kr) channels.
    Pond AL; Scheve BK; Benedict AT; Petrecca K; Van Wagoner DR; Shrier A; Nerbonne JM
    J Biol Chem; 2000 Feb; 275(8):5997-6006. PubMed ID: 10681594
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The N-linker region of hERG1a upregulates hERG1b potassium channels.
    Johnson AA; Crawford TR; Trudeau MC
    J Biol Chem; 2022 Sep; 298(9):102233. PubMed ID: 35798139
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A stable cell line inducibly expressing hERG1a/1b heteromeric channels.
    Ríos-Pérez EB; Liu F; Stevens-Sostre WA; Eichel CA; Silignavong J; Robertson GA
    J Pharmacol Toxicol Methods; 2021; 110():107081. PubMed ID: 34058320
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.